184 related articles for article (PubMed ID: 36892249)
1. Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure.
Deng X; Jiang N; Huang C; Zhou S; Peng L; Zhang L; Liu J; Wang L; Zhou J; Wang Q; Weng L; Peng J; Zhao J; Li M; Zeng X
Int J Rheum Dis; 2023 May; 26(5):862-869. PubMed ID: 36892249
[TBL] [Abstract][Full Text] [Related]
2. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Bai Y; Yang J; Liu J; Ning H; Zhang R
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of pulmonary hypertension associated with connective tissue disease: pulmonary artery size measured by chest CT.
Li X; Zhang C; Sun X; Yang X; Zhang M; Wang Q; Zhu Y
Rheumatology (Oxford); 2020 Nov; 59(11):3221-3228. PubMed ID: 32221604
[TBL] [Abstract][Full Text] [Related]
4. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases.
Luo YF; Robbins IM; Karatas M; Brixey AG; Rice TW; Light RW
Chest; 2011 Jul; 140(1):42-47. PubMed ID: 21212140
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
6. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China.
Zhao J; Wang Q; Liu Y; Tian Z; Guo X; Wang H; Lai J; Huang C; Yang X; Li M; Zeng X
Int J Cardiol; 2017 Jun; 236():432-437. PubMed ID: 28159359
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.
Ngian GS; Stevens W; Prior D; Gabbay E; Roddy J; Tran A; Minson R; Hill C; Chow K; Sahhar J; Proudman S; Nikpour M
Arthritis Res Ther; 2012 Oct; 14(5):R213. PubMed ID: 23039366
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry.
Kang KY; Jeon CH; Choi SJ; Yoon BY; Choi CB; Lee CH; Suh CH; Lee CW; Cho CS; Nam EJ; Koh EM; Kim HY; Choi HJ; Kim HA; Jun JB; Lee J; Kim J; Ji JD; Min JK; Kim KJ; Shin K; So MW; Kwon SR; Kim SK; Nah SS; Kwok SK; Lee SK; Lee SW; Park SH; Park W; Park YB; Lee YH; Lee SS; Yoo DH
Int J Rheum Dis; 2017 Sep; 20(9):1227-1236. PubMed ID: 26214170
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension.
Nakayama K; Nakajima Y; Tanaka R; Hirata KI; Emoto N
J Clin Rheumatol; 2021 Dec; 27(8):e371-e377. PubMed ID: 32511146
[TBL] [Abstract][Full Text] [Related]
11. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
12. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
[TBL] [Abstract][Full Text] [Related]
14. Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.
Lowery MM; Hill NS; Wang L; Rosenzweig EB; Bhat A; Erzurum S; Finet JE; Jellis CL; Kaur S; Kwon DH; Nawabit R; Radeva M; Beck GJ; Frantz RP; Hassoun PM; Hemnes AR; Horn EM; Leopold JA; Rischard FP; Mehra R;
J Am Coll Cardiol; 2023 Nov; 82(21):1989-2005. PubMed ID: 37968017
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of pulmonary arterial hypertension secondary to connective tissue disease in children].
Xing Y; Song HM; Wu XY; He YY; Wei M
Zhonghua Er Ke Za Zhi; 2008 Nov; 46(11):822-6. PubMed ID: 19099898
[TBL] [Abstract][Full Text] [Related]
16. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.
Condliffe R; Kiely DG; Peacock AJ; Corris PA; Gibbs JS; Vrapi F; Das C; Elliot CA; Johnson M; DeSoyza J; Torpy C; Goldsmith K; Hodgkins D; Hughes RJ; Pepke-Zaba J; Coghlan JG
Am J Respir Crit Care Med; 2009 Jan; 179(2):151-7. PubMed ID: 18931333
[TBL] [Abstract][Full Text] [Related]
18. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
Ji YQ; Zhang ZL; Lu WX
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):467-71. PubMed ID: 16831323
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.
Campo A; Mathai SC; Le Pavec J; Zaiman AL; Hummers LK; Boyce D; Housten T; Lechtzin N; Chami H; Girgis RE; Hassoun PM
Eur Respir J; 2011 Aug; 38(2):359-67. PubMed ID: 21310884
[TBL] [Abstract][Full Text] [Related]
20. Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.
Fischer A; Denton CP; Matucci-Cerinic M; Gillies H; Blair C; Tislow J; Nathan SD
Respir Med; 2016 Aug; 117():254-63. PubMed ID: 27492539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
